Hook3434 Hook EB. Chromosome abnormalities and spontaneous fetal death following amniocentesis: further data and associations with maternal age. Am J Hum Genet. 1983; 35(1):110-6.
|
1983 |
direct |
AMNIO |
50 (4) |
67 (21) |
33 (52) |
82 (11) |
Hook et al.4545 Hook EB, Topol BB, Cross PK. The natural history of cytogenetically abnormal fetuses detected at midtrimester amniocentesis which are not terminated electively: new data and estimates of the excess and relative risk of late fetal death associated with 47, 21 and some other abnormal karyotypes. Am J Hum Genet. 1989; 45(6):855-61.
|
1989 |
direct |
AMNIO |
33 (3) |
68 (15) |
27 (37) |
50 (4) |
|
Hook et al.4848 Hook EB, Mutton DE, Ide R, Alberman E, Bobrow M. The natural history of Down syndrome conceptuses diagnosed prenatally that are not electively terminated. Am J Hum Genet. 1995; 57(4):875-81.
|
1995 |
direct |
AMNIO |
- |
- |
35 (168) |
- |
Halliday et al.6161 Halliday JL, Watson LF, Lumley J, Danks DM, Sheffield LJ. New estimates of Down syndrome risks at chorionic villus sampling, amniocentesis, and live birth in women of advanced maternal age from a uniquely defined population. Prenat Diagn. 1995; 15(5):455-65.
|
1995 |
indirect |
CVS |
- |
- |
31 (NR) |
- |
|
|
|
AMNIO |
- |
- |
18 (NR) |
- |
Macintosh et al.6262 Macintosh MC, Wald NJ, Chard T, Hansen J, Mikkelsen M, Therkelsen AJ, et al. Selective miscarriage of Down's syndrome fetuses in women aged 35 years and older. Br J Obstet Gynaecol. 1995; 102(10):798-801.
|
1995 |
indirect |
CVS |
- |
- |
54 (71) |
- |
Snijders et al.5050 Snijders R, Sebire NHC, Nicolaides K. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diag Ther. 1995; 10(6):356-67.
|
1995 |
indirect |
CVS |
83 (NR) |
86 (NR) |
47 (NR) |
76 (NR) |
|
|
|
AMNIO |
71 (NR) |
74 (NR) |
31 (NR) |
52 (NR) |
Gravholt et al.7575 Gravholt CH, Juul S, Naeraa RW, Hansen J. Prenatal and postnatal prevalence of Turners syndrome: a registry study. BMJ. 1996; 312(7022):16-21.
|
1996 |
direct |
CVS |
– |
– |
– |
40 (5) |
|
|
|
AMNIO |
– |
– |
– |
25 (8) |
Bray e Wright6060 Bray IC, Wright DE. Estimating the spontaneous loss of Down syndrome fetuses between the times of chorionic villus sampling, amniocentesis and live birth. Prenat Diagn. 1998; 18(10):1045-54.
|
1998 |
indirect |
CVS |
– |
– |
39 (NR) |
– |
|
|
|
AMNIO |
– |
– |
12 (NR) |
– |
Snijders et al.6363 Snijders R, Sundberg K, Holzgreve W, Henry G, Nicolaides K. Maternal age and gestation-specific risk for trisomy 21. Ultrassound Obstet Gynecol. 1999; 13(3):167-70.
|
1999 |
indirect |
CVS |
– |
– |
30 (NR) |
– |
|
|
|
AMNIO |
– |
– |
21 (NR) |
– |
Morris et al.6464 Morris JK, Wald NJ, Watt HC. Fetal loss in Down syndrome pregnancies. Prenat Diagn. 1999; 19(2):142-5.
|
1999 |
indirect |
CVS |
– |
– |
31 (NR) |
– |
|
|
|
AMNIO |
– |
– |
24 (NR) |
– |
Cuckle6565 Cuckle H. Down syndrome fetal loss rate in early pregnancy. Prenat Diagn. 1999; 19(12):1177-9.
|
1999 |
indirect |
CVS |
– |
– |
45-46 (NR) |
– |
|
|
|
AMNIO |
– |
– |
22-24 (NR) |
– |
Surerus et al.7676 Surerus E, Huggon IC, Allan LD. Turners syndrome in fetal life. Ultrasound Obstet Gynecol. 2003; 22(3):264-7.
|
2003 |
direct |
CVS |
– |
– |
- |
75 (8) |
Won et al.2929 Won RH, Currier RJ, Lorey F, Towner DR. The timing of demise in fetuses with trisomy 21 and trisomy 18. Prenat Diagn. 2005; 25(7):608-11.
|
2005 |
direct |
AMNIO |
– |
32 (106) |
10 (392) |
– |
Alberman et al.7070 Alberman E, Mutton D, Morris JK. Cytological and epidemiological findings in trisomies 13, 18, and 21: England and Wales 2004-2009. Am J Med Genet A. 2012; 158A(5):1145-50.
|
2012 |
direct |
AMNIO |
21(NR) |
36 (NR) |
7 (NR) |
– |
Yamanaka et al.4444 Yamanaka M, Setoyama T, Igarashi Y, Kurosawa K, Itani Y, Hashimoto S, et al. Pregnancy outcome of fetuses with trisomy 18 identified by prenatal sonography and chromosomal analysis in a perinatal center. Am J Med Genet A. 2006; 140(11):1177-82.
|
2006 |
direct |
AMNIO |
- |
45 (58) |
– |
– |
Morris e Savva6666 Morris JK, Savva GM. The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18. Am J Med Genet A. 2008; 146(7):827-32.
|
2008 |
direct |
|
47 (19) |
70 (80) |
– |
– |
Crider et al.3232 Crider KS, Olney RS, Cragan JD. Trisomies 13 and 18: population prevalences, characteristics, and prenatal diagnosis, metropolitan Atlanta, 1994-2003. Am J Med Genet A. 2008; 146(7):820-6.
|
2008 |
direct |
|
50 (20) |
63 (57) |
– |
– |
Irving et al.2626 Irving C, Richmond S, Wren C, Longster C, Embleton ND. Changes in fetal prevalence and outcome for trisomies 13 and 18: a population-based study over 23 years. J Matern Fetal Neonatal Med. 2011; 24(1):137-41.
|
2011 |
direct |
|
29 (7) |
100 (32) |
– |
– |
Lakovschek et al.4646 Lakovschek IC, Streubel B, Ulm B. Natural outcome of trisomy 13, trisomy 18, and triploidy after prenatal diagnosis. Am J Med Genet A. 2011; 155A(11):2626-33.
|
2011 |
direct |
|
67 (3) |
87 (15) |
– |
– |
Burke et al.4747 Burke AL, Field K, Morrison JJ. Natural history of fetal trisomy 18 after prenatal diagnosis. Arch Dis Child Fetal Neonatal Ed. 2013; 98(2):F152-4.
|
2013 |
direct |
|
– |
61 (23) |
– |
– |
Iyer et al.4949 Iyer NP, Tucker DF, Roberts SH, Moselhi M, Morgan M, Matthes JW. Outcome of fetuses with Turner syndrome: a 10-year congenital anomaly register based study. J Matern Fetal Neonatal Med. 2012; 25(1):68-73.
|
2012 |
direct |
AMNIO/BVC |
– |
– |
– |
40 (20) |